Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Return on Capital Employed (2021 - 2024)

Historic Return on Capital Employed for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to 0.21%.

  • Burning Rock Biotech's Return on Capital Employed rose 3800.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year increase of 3800.0%. This contributed to the annual value of 0.5% for FY2024, which is 1200.0% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Return on Capital Employed of 0.21% as of Q3 2025, which was up 3800.0% from 0.24% recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Return on Capital Employed ranged from a high of 0.19% in Q4 2021 and a low of 0.82% during Q4 2022
  • For the 5-year period, Burning Rock Biotech's Return on Capital Employed averaged around 0.51%, with its median value being 0.59% (2022).
  • In the last 5 years, Burning Rock Biotech's Return on Capital Employed crashed by -10100bps in 2022 and then soared by 5400bps in 2025.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Return on Capital Employed stood at 0.19% in 2021, then crashed by -538bps to 0.82% in 2022, then grew by 1bps to 0.81% in 2023, then surged by 35bps to 0.52% in 2024, then skyrocketed by 60bps to 0.21% in 2025.
  • Its Return on Capital Employed stands at 0.21% for Q3 2025, versus 0.24% for Q2 2025 and 0.4% for Q1 2025.